Combination Therapy Enhances Stem Cell Mobilization in Patients With Multiple Myeloma
A phase III trial evaluated intermediate-dose cytarabine plus granulocyte-colony stimulating factor (G-CSF) vs G-CSF alone prior to autoSCT in multiple myeloma.